Business Segments GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:14 2025-06-16 EDT			5-day change	1st Jan Change
1,485.50 ^GBX	-1.72%		-1.82%	+10.32%

06-16	Stocks up on hopes of thaw to Middle East tension	AN
06-13	Alector, Inc. Announces Chief Financial Officer Changes	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (GBP)

Fiscal Period: December	2020	2021	2022	2023	2024
Biological Products
Commercial Operations	-	-	29.32B	30.33B	31.38B
D&A	-	-	829M	893M	906M
Operating Income	-	-	13.59B	14.66B	15.34B
Pharmaceutical Research and Development
D&A	298M	325M	467M	572M	569M
Operating Income	-3.54B	-3.49B	-5.06B	-5.61B	-5.84B
Dental Care Products
Consumer Healthcare	10.03B	9.61B	-	-	-
D&A	235M	226M	-	-	-
Operating Income	2.21B	2.24B	-	-	-
Corporate and Other Unallocated Turnover	28M	-	-	-	-
Operating Income	-205M	-370M	-379M	-263M	-342M
D&A	82M	54M	112M	110M	74M
D&A	775M	802M	739M	719M	1B
Corporate and Other	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceutical Products
Pharmaceuticals - Global Pharmaceuticals	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Vaccines	6.98B	6.78B	-	-	-
D&A	404M	416M	-	-	-
Operating Income	2.71B	2.26B	-	-	-
Pharmaceuticals - HIV	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceuticals	17.06B	17.73B	-	-	-
D&A	557M	553M	-	-	-
Operating Income	7.72B	8.17B	-	-	-

Geographical breakdown of sales (GBP)

Fiscal Period: December	2020	2021	2022	2023	2024
United States (US)	14.56B	15.09B	14.54B	15.82B	16.38B
Total Assets	17.9B	17.85B	14.02B	13.28B	13.98B
Operating Income	-	-	-	-	-
International	18.56B	18.05B	14.09B	13.82B	14.28B
Total Assets	27.71B	15.39B	6.56B	6.61B	5.59B
Operating Income	-	-	-	-	-
United Kingdom (UK)	980M	975M	695M	693M	708M
Total Assets	6.28B	6.62B	5.13B	6.46B	7.8B
Operating Income	-	-	-	-	-
Total Assets	-	5.06B	5.42B	5.34B	5.38B
Total Assets	-	6.55B	34M	-	-
Inter-Segment Turnover	-	-	-	-	-